Norris Financial Group’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Norris Financial Group’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-22	Closed	-$5.51K	–	84
2019 Q4	$5.51K	Buy	+22	New	+$4.29K	0.01%	55

Other funds holding TMBR

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Norris Financial Group's TMBR Position: Q1 2020 in Review

Norris Financial Group sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2020, closing a stake of 22 shares — an estimated $5.51K sold.

Norris Financial Group first reported a position in TMBR in Q4 2019 and held it in 1 quarter. The position peaked at $5.51K in Q4 2019. 7 funds tracked by Wall St. Rank hold TMBR as of Q1 2020.

Norris Financial Group reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Norris Financial Group sold 22 Timber Pharmaceuticals, Inc. shares in Q1 2020, an estimated $5.51K.
Norris Financial Group first reported a position in Timber Pharmaceuticals, Inc. in Q4 2019 and held it in 1 quarter.
Norris Financial Group's Timber Pharmaceuticals, Inc. position peaked at $5.51K in Q4 2019.
7 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2020.

Based on Norris Financial Group's 13F filing for Q1 2020, filed 2 Jun 2026.